Advanced Phasing Techniques in Congenital Skin Diseases

Overview

Journal J Dermatol

Specialty Dermatology

Date 2024 Dec 26

PMID 39723554

Authors

Ken Natsuga

Affiliations

Soon will be listed here.

Abstract

Phasing, the process of determining which alleles at different loci on homologous chromosomes belong together on the same chromosome, is crucial in the diagnosis and management of autosomal recessive diseases. Advances in long-read sequencing technologies have significantly enhanced our ability to accurately determine haplotypes. This review discusses the application of low-coverage long-read sequencing, nanopore Cas9-guided long-read sequencing, and adaptive sampling in phasing, highlighting their utility in complex clinical scenarios. Through clinical vignettes, we explore the importance of phasing in gene therapy design for recessive dystrophic epidermolysis bullosa and the role of revertant mosaicism in therapeutic epidermal autografts. Despite its promise, phasing with long-read sequencing faces challenges, including low efficiency in enriching target regions and the inherent error rate of nanopore sequencing. Future developments in long-read sequencing technologies will be critical in overcoming these limitations and expanding the applicability of phasing across various clinical settings.

Citing Articles

Advanced phasing techniques in congenital skin diseases.

Natsuga K J Dermatol. 2024; 52(3):392-399.

PMID: 39723554 PMC: 11883850. DOI: 10.1111/1346-8138.17597.

References

Zhang Z, Li C, Wu F, Ma R, Luan J, Yang F . Genomic variations of the mevalonate pathway in porokeratosis. Elife. 2015; 4:e06322. PMC: 4511816. DOI: 10.7554/eLife.06322. View

Kubo A, Sasaki T, Suzuki H, Shiohama A, Aoki S, Sato S . Clonal Expansion of Second-Hit Cells with Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes. J Invest Dermatol. 2019; 139(12):2458-2466.e9. DOI: 10.1016/j.jid.2019.05.020. View

Gostynski A, Pasmooij A, Jonkman M . Successful therapeutic transplantation of revertant skin in epidermolysis bullosa. J Am Acad Dermatol. 2013; 70(1):98-101. DOI: 10.1016/j.jaad.2013.08.052. View

Kotzot D, Utermann G . Uniparental disomy (UPD) other than 15: phenotypes and bibliography updated. Am J Med Genet A. 2005; 136(3):287-305. DOI: 10.1002/ajmg.a.30483. View

Meyerhans A, Vartanian J, Wain-Hobson S . DNA recombination during PCR. Nucleic Acids Res. 1990; 18(7):1687-91. PMC: 330584. DOI: 10.1093/nar/18.7.1687. View

Matsumura W, Fujita Y, Shinkuma S, Suzuki S, Yokoshiki S, Goto H . Cultured Epidermal Autografts from Clinically Revertant Skin as a Potential Wound Treatment for Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2019; 139(10):2115-2124.e11. DOI: 10.1016/j.jid.2019.03.1155. View

Nomura T, Sandilands A, Akiyama M, Liao H, Evans A, Sakai K . Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol. 2007; 119(2):434-40. DOI: 10.1016/j.jaci.2006.12.646. View

Conlin L, Aref-Eshghi E, McEldrew D, Luo M, Rajagopalan R . Long-read sequencing for molecular diagnostics in constitutional genetic disorders. Hum Mutat. 2022; 43(11):1531-1544. PMC: 9561063. DOI: 10.1002/humu.24465. View

Natsuga K . Advanced phasing techniques in congenital skin diseases. J Dermatol. 2024; 52(3):392-399. PMC: 11883850. DOI: 10.1111/1346-8138.17597. View

10.

Has C, Bauer J, Bodemer C, Bolling M, Bruckner-Tuderman L, Diem A . Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020; 183(4):614-627. DOI: 10.1111/bjd.18921. View

11.

Palmer C, Irvine A, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee S . Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006; 38(4):441-6. DOI: 10.1038/ng1767. View

12.

Natsuga K, Furuta Y, Takashima S, Nohara T, Kosumi H, Mai Y . Detection of revertant mosaicism in epidermolysis bullosa through Cas9-targeted long-read sequencing. Hum Mutat. 2022; 43(4):529-536. DOI: 10.1002/humu.24331. View

13.

Natsuga K, Nishie W, Arita K, Shinkuma S, Nakamura H, Kubota S . Complete paternal isodisomy of chromosome 17 in junctional epidermolysis bullosa with pyloric atresia. J Invest Dermatol. 2010; 130(11):2671-4. DOI: 10.1038/jid.2010.182. View

14.

Natsuga K, Furuta Y, Takashima S, Nohara T, Huang H, Shinkuma S . Cas9-guided haplotyping of three truncation variants in autosomal recessive disease. Hum Mutat. 2022; 43(7):877-881. DOI: 10.1002/humu.24385. View

15.

Lei K, Shelly L, Pan C, Sidbury J, Chou J . Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science. 1993; 262(5133):580-3. DOI: 10.1126/science.8211187. View

16.

Atzmony L, Khan H, Lim Y, Paller A, Levinsohn J, Holland K . Second-Hit, Postzygotic PMVK and MVD Mutations in Linear Porokeratosis. JAMA Dermatol. 2019; 155(5):548-555. PMC: 6506890. DOI: 10.1001/jamadermatol.2019.0016. View

17.

Gilpatrick T, Lee I, Graham J, Raimondeau E, Bowen R, Heron A . Targeted nanopore sequencing with Cas9-guided adapter ligation. Nat Biotechnol. 2020; 38(4):433-438. PMC: 7145730. DOI: 10.1038/s41587-020-0407-5. View

18.

Miyauchi T, Suzuki S, Takeda M, Peh J, Aiba M, Natsuga K . Altered replication stress response due to CARD14 mutations promotes recombination-induced revertant mosaicism. Am J Hum Genet. 2021; 108(6):1026-1039. PMC: 8206392. DOI: 10.1016/j.ajhg.2021.04.021. View

19.

Natsuga K, Sawamura D, Goto M, Homma E, Goto-Ohguchi Y, Aoyagi S . Response of intractable skin ulcers in recessive dystrophic epidermolysis bullosa patients to an allogeneic cultured dermal substitute. Acta Derm Venereol. 2010; 90(2):165-9. DOI: 10.2340/00015555-0776. View

20.

Nomura T . Recombination-induced revertant mosaicism in ichthyosis with confetti and loricrin keratoderma. J Dermatol Sci. 2020; 97(2):94-100. DOI: 10.1016/j.jdermsci.2019.12.013. View